A Renewed Understanding of Tumor Growth Modulation by Tumor Necrosis Factor (TNF)-Associated Pathways
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Molecular Cancer Biology".
Deadline for manuscript submissions: 15 October 2026 | Viewed by 97
Special Issue Editor
2. Division of Animal Sciences, College of Agriculture, Food and Natural Resources, University of Missouri, Columbia, MO 65202, USA
Interests: epigenetics; TNF; IGF1; inflammation; immune regulation
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The pro-inflammatory role of TNF has been a subject of intense clinical investigation for over fifty years. Recent advancements have identified several molecular pathways regulated by TNF and its receptors. The nuances of crosstalk and feedback regulation have further expanded the field, leading to the identification of new molecular targets. Additionally, the role of epigenetics and insights gained from microRNA mediation have made distinct contributions to this evolving field.
This Special Issue aims to highlight recent advancements in TNF-mediated modulations in cancer, as well as associated pathways and their molecular mediators. Finally, the use of specific inhibitors as potential drug candidates targeting proteins that promote tumor growth, inflammation, metastasis, and other aspects of tumor biology is discussed.
Dr. Chandra Shekhar Boosani
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- tumor
- inflammation
- epigenetics
- immune system
- inhibitors
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
